Clinical trial of a new diuretic, bumetanide, in seriously ill patients.
D058186:Acute Kidney Injury / Q000188:drug therapy; D000293:Adolescent; D000328:Adult; D000368:Aged; D001565:Benzoates / Q000494:pharmacology / Q000627:therapeutic use*; D002082:Butylamines / Q000494:pharmacology / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004232:Diuretics / Q000494:pharmacology / Q000627:therapeutic use*; D004487:Edema / Q000188:drug therapy*; D005260:Female; D005665:Furosemide / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D008103:Liver Cirrhosis / Q000188:drug therapy; D008138:Loop of Henle / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D009404:Nephrotic Syndrome / Q000188:drug therapy; D010647:Phenyl Ethers / Q000494:pharmacology / Q000627:therapeutic use; D010919:Placebos; D012964:Sodium / Q000652:urine
D001565:Benzoates; D002082:Butylamines; D004232:Diuretics; D010647:Phenyl Ethers; D010919:Placebos; D005665:Furosemide; D012964:Sodium